Research news

UCLH has recruited the first participant in Europe to a global clinical trial for adults with Myotonic Dystrophy Type 1 (DM1)- a genetic condition and type of muscular dystrophy that causes progressive muscle weakness and wasting.

A study has shed light on multiple factors in the recruitment process in research that act as barriers to the recruitment of patients from minority ethnic groups to trials.

UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.

A technique to improve the precision of prostate cancer surgery means that almost twice as many men preserve their erectile function compared to those undergoing standard surgery, according to results from a clinical trial led by researchers from UCL and UCLH.

A new UCLH-hosted National Institute of Health and Care Research (NIHR) funded study will address health, education and social care outcomes for marginalised children and young people. This work will explore what works, what does not work, identify important gaps in practice, law and policy - and consider what we might do to address these.